The research service presents an overview and analysis of the China contract research organisation (CRO) market. It provides revenue forecasts by phase and therapeutic type and discusses the major issues and challenges, unmet needs, and emerging trends in the market. The study also covers the complete life cycle of the CRO industry, starting from preclinical to late phase clinical trials. It provides detailed information about support services such as central laboratory services, bioanalytics, and data management, and analyses market engineering measurements and research and development trends.